Clairity logo

AI Image-based Risk Now Available in Luminary Risk

Now available in Luminary Risk:
Clairity Breast, the first and only FDA-authorized, AI image-based risk assessment for breast cancer.

AI Image-based Risk Now Available in Luminary Risk

Breast Imaging Center News and Updates Blog

Breast imaging news, workflow tips, and more

breast arterial calcification

Tens of millions of women undergo screening mammography in the U.S. each year, making it one …

what is a mammography technologist

In April of 2026, the National Comprehensive Cancer Network® (NCCN®) updated its 2026 NCCN Clinical Practice …

healthcare analytics

Screening programs generate a lot of data. But one metric tells you more than almost any …

women marking off a list with check marks

Breast cancer risk assessment has become a crucial tool in modern breast screening programs, and the …

women having a mammogram

The rapid advancement of breast cancer screening and prevention technology is cause for excitement and hope in our industry, with AI breast cancer risk assessment quickly moving to the forefront.

magview, clairity breast and myriad genetics

Integrated AI, genetic, and imaging solutions from Clairity, Myriad, and MagView help identify high-risk women and enable earlier breast cancer intervention.

Partnership Know Your Lemons and MagView

We’re thrilled to announce MagView’s partnership with the Know Your Lemons Foundation—a global leader in innovative …

breast_dense_Scan

An exciting technique in mammography, Contrast-Enhanced Mammography (CEM) is an increasingly important and effective method providers …

SDMI and MagView

Fulton, MD – Tuesday, July 22, 2025 – MagView, the leader in mammography tracking and reporting, …

Request A Demo

Request a Demo